Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / P••••••• T•••••••••

P••••••• T•••••••••

Series BUS
Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
1
Disclosed raised
$47.0Msum of rounds with a disclosed amount only
Named investors
7
Financing history
1 rounds
  1. Oct 28, 2025
    Series B · $47.0M (disclosed)
    W••••• I••••••••• (participant)S••• V••••••• (participant)S•••• G•••• I••••••••• (participant)A••••• I••••••••• (participant)S• I••••••••• (participant)S• I••••••••• P••••••• (participant)S•••••••• I••••••••• (participant)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “P••••••• T••••••••• Raises $47 Million in Oversubscribed Series B to Advance Next-Generation Protein Degraders in Oncology”
Investors on record
7 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
1
  1. Oct 28, 2025
    P••••••• T••••••••• announced Series B of $47,000,000
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
Evidence
1 observations
Every observation on this company